Aetiology
- Idiopathic
- Obstruction
- Choledocolithiasis
- Ampullary or pancreatic tumours
- Pancreatic structural anomalies
- Toxins
- Alcohol
- Drugs - salicylates, azathioprine, cimetidine
- Trauma
- Metabolic abnormalities
- Infection
- Vascular anomalies
Diagnosis
- Serum amylase has low sensitivity and specificity
- 20% cases of pancreatitis have normal serum amylase (particularly alcoholic aetiology)
- Serum lipase more sensitive


Pictures provided by Vikram Kate, Jawaharial Institute of Postgraduate Medical Education and
Research, Pondicherry, India
Causes of hyperamylasaemia
- Perforated peptic ulcer
- Cholecystitis
- Generalised peritonitis
- Intestinal obstruction
- Mesenteric infarction
- Ruptured AAA
- Ruptured ectopic pregnancy
Prognostic factors
- 80% of patients have mild pancreatitis with good recovery
- Mild disease accounts for less than 5% of the mortality form pancreatitis
- Mortality from pancreatitis due to:
- Early multiple organ failure
- Late infected pancreatic necrosis
- Haemorrhage
- Associated co-morbidity
- Aim of prognostic scores is to identify patients with severe pancreatitis
- Need to have high sensitivity and specificity
- Ideally should be applicable on admission
Ranson's criteria
- On admission
- Age > 55 yrs
- WCC > 16,000
- LDH > 600 U/l
- AST >120 U/l
- Glucose > 10 mmol/l
- Within 48 hours
- Haematocrit fall >10%
- Urea rise >0.9 mmol/l
- Calcium < 2 mmol
- pO2 < 60 mmHg
- Base deficit > 4
- Fluid sequestration > 6L
- Can not be applied fully for 48 hours
- Also poor predictor later in the disease
- 'Single snapshot in a whole feature length film'
APACHE II score
- Multivariate scoring system
- Measure objective parameter - vital signs and biochemical analysis
- Account for premorbid state and age
- Can be used throughout course of illness
Contrast-enhanced CT scoring system
| Grade |
Criteria |
| A |
Normal |
| B |
Focal or diffuse glandular enlargement |
|
Small intra-pancreatic fluid collection |
| C |
Any of the above |
|
Peripancreatic inflammatory changes |
|
Less than 25% gland necrosis |
| D |
Any of the above |
|
Single extrapancreatic fluid collection |
|
25-50% gland necrosis |
| E |
Any of the above |
|
Extensive extrapancreatic fluid collection |
|
Pancreatic abscess |
|
More than 50% gland necrosis |
Early treatment
- Aims of treatment are to :
- To halt progression of local disease
- Prevent remote organ failure
- Requires full supportive therapy – often on ITU or HDU
- Urinary catheter, CVP line and possibly arterial line
- Regular assessment of U+Es, Ca, blood sugar, LFTs
- Patients require:
- Fluid resuscitation with both colloid and crystalloid
- Correction of hypoxia with an increased inspired oxygen or ventilation
- Adequate analgesia - opiate or epidural
- Increasing evidence that antibiotic prophylaxis useful in severe pancreatitis
Nutritional support
- Pancreatitis is associated with a catabolic state
- The benefit of pancreatic 'rest' by limiting oral intake is unproven
- Evidence that early enteral nutrition is safe
- Nasojejunal feeding limits pancreatic secretion
- Preferable to oral or nasogastric feeding
Complications of acute pancreatitis
Local
- Necrosis +/- infection
- Pancreatic fluid collections
- Colonic necrosis
- Gastrointestinal haemorrhage
- Splenic rupture
Systemic
- Hypovolaemia and shock
- Coagulopathy
- Respiratory failure
- Renal Failure
- Hyperglycaemia
- Hypocalcaemia
Pseudocysts
- Fibrous walled peri-pancreatic fluid collection
- Present for more than 1 month
- No epithelial lining. Fluid has high amylase content
- Acute fluid collections are not pseudocysts
- 35% patients with pancreatitis develop peri-pancreatic fluid collections
- More than 50% resolve spontaneously over a 3 month period
- Complication rate increases after 6 weeks
- Diagnosis may be suggested by persistent elevation of serum amylase
- Planned intervention at 6 weeks
Classification of pseudocysts
- Type 1 - normal duct anatomy. No fistula between duct and cyst
- Type 2 - abnormal duct anatomy - No fistula
- Type 3 - abnormal duct anatomy and fistula
Investigation of pseudocysts
- Ultrasound will allow assessment of changes in the size of the cyst
- Endoscopic ultrasound increasingly used
- CT to define relationship to adjacent organs

- ERCP to define duct anatomy
Treatment options
Percutaneous drainage
- Ultrasound or CT guided
- 80% successful in type 1 cyst
- Less successful if fistula to duct present
- Occasionally associated with pancreatic abscess or fistula
Endoscopic drainage + insertion of pigtail catheter
- Transpapillary or transmural
Surgical drainage
- Cystogastrotomy
- Roux Loop Cystojejunostomy
- Allows adequate internal drainage
- Biopsy cyst wall to exclude cystadenocarcinoma
- Mortality similar to percutaneous drainage ( 5%)
- Lower recurrence rate ( approximately 5 vs. 20%)
Timing of intervention in pancreatitis
- All patients should undergo ultrasound within 24 hours of admission
- If confirms gallstones and severe pancreatitis consider ERCP within 48 hrs
- RCT confirm reduction in morbidity and mortality with early duct clearance
- If patient fails to settle during first week of admission
- Contrast enhanced CT to assess pancreatic necrosis
- If suspicion of infection - CT guided aspiration
- Consider pancreatic necrosectomy if
- Clinical deterioration
- Bacteriological proof on infection
- Operative mortality >40%

Picture provided by Jean-Pierre Arsenault, University of Montreal, Coventry.
Bibliography
Beckingham I J, Krige J E J,
Bornman C, Terblanche J. Endoscopic management of pancreatic pseudocysts. Br
J Surg 1997; 84:
1638-1645.
Formela L J. Inflammatory mediators in
acute pancreatitis. Br J Surg 1995; 82: 6 - 16.
Glazer G, Mann D V et
al. United Kingdom guidelines for the management of acute pancreatitis.
Gut 1998; 42 (Suppl 2); S1-S13.
Grace P A Williamson R C.
Modern management of pancreatic pseudocysts. Br
J Surg 1993; 80: 573 581.
Gupta R, Toh S K C,
Johnson C D. Early ERCP is an essential part of the
management of all cases of acute pancreatitis.
Ann R Coll Surg Engl 1999; 81:
46-50.
Johnson C D. Timing of intervention in
acute pancreatitis. Post Grad Med J 1993; 69: 509 -515.
Johnson C D. Severe acute pancreatitis:
a continuing challenge for the intensive care team. Br J Intensive Med 1998;
8: 130-138.
Kingsnorth A. Diagnosing acute
pancreatitis: room for improvement ? Hosp
Med 1998; 59: 191-194.
Lobo D N, Memon M A, Allison S P, Rowlands B J. Evolution of
nutritional support in acute pancreatitis. Br J Surg 2000; 87: 695-707.
Moran B, Rew D A,
Johnson C D. Pancreatic pseudocysts should be treated by
surgical drainage. Ann R Col Surg Eng 1994; 76: 54 - 58.
Murphy J O, Mehigan B J, Keane F B. Acute pancreatitis. Hosp
Med 2002; 63: 487-892.
Powell J J, Parks R W. Diagnosis and early management of acute
pancreatitis. Hosp Med 2003; 64: 150-155.
Powell J J, Miles R,
Siriwardena A K. Antibiotic prophylaxis in the initial
management of severe acute pancreatitis. Br
J Surg 1998; 85: 582-587.
Skaife P, Kingsnorth A N.
Acute pancreatitis: assessment and management. Post
Grad Med J 1996; 72: 277 -283.
Steinberg W Tenner S.
Acute Pancreatitis. N Eng J Med 1994; 330: 1198 - 1210.
Yousaf M, McCallion K, Diamond T. Management of severe acute
pancreatitis. Br J Surg 2003; 90: 407-420 |